BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21276105)

  • 41. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.
    Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN
    Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
    Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
    Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
    Ademi Z; Liew D; Hollingsworth B; Wolfe R; Steg GP; Bhatt DL; Reid CM;
    Clin Ther; 2010 Jan; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A cost function analysis of shigellosis in Thailand.
    Riewpaiboon A; Youngkong S; Sreshthaputra N; Stewart JF; Samosornsuk S; Chaicumpa W; von Seidlein L; Clemens JD
    Value Health; 2008 Mar; 11 Suppl 1():S75-83. PubMed ID: 18387071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The mounting medical care cost for adult AIDS patients at the Faculty of Medicine, Siriraj Hospital: consideration for management.
    Suwanagool S; Ratanasuwan W; Techasathit W
    J Med Assoc Thai; 1997 Jul; 80(7):431-9. PubMed ID: 9277072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The economic cost of myopia in adults aged over 40 years in Singapore.
    Zheng YF; Pan CW; Chay J; Wong TY; Finkelstein E; Saw SM
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7532-7. PubMed ID: 24159089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Costs of temporary disability in Spain related to diabetes mellitus and its complications].
    Vicente-Herrero MT; Terradillos García MJ; Capdevila García LM; Ramírez Iñiguez de la Torre MV; López-González AA
    Endocrinol Nutr; 2013 Oct; 60(8):447-55. PubMed ID: 23726468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Economic analysis of the diabetes and hypertension screening collaboration between community pharmacies and a Thai government primary care unit.
    Sookaneknun P; Saramunee K; Rattarom R; Kongsri S; Senanok R; Pinitkit P; Sawangsri W; Deesin B
    Prim Care Diabetes; 2010 Oct; 4(3):155-64. PubMed ID: 20558122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indirect costs of diabetes and its impact on the public finance: the case of Poland.
    Torój A; Mela A
    Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):93-105. PubMed ID: 28796563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Direct costs of diabetes mellitus in Germany: first estimation of the differences related to educational level].
    Korber K; Teuner CM; Lampert T; Mielck A; Leidl R
    Gesundheitswesen; 2013 Dec; 75(12):812-8. PubMed ID: 24132596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach.
    Marcellusi A; Viti R; Mecozzi A; Mennini FS
    Eur J Health Econ; 2016 Mar; 17(2):139-47. PubMed ID: 25427540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.
    Oh SH; Ku H; Park KS
    BMC Public Health; 2021 Mar; 21(1):548. PubMed ID: 33743612
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
    Bommer C; Heesemann E; Sagalova V; Manne-Goehler J; Atun R; Bärnighausen T; Vollmer S
    Lancet Diabetes Endocrinol; 2017 Jun; 5(6):423-430. PubMed ID: 28456416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Economic Burden of Hospitalization with Acute Wheezing in Preschool Children: A Multi-Center Study.
    Sritipsukho P; Matchimmadamrong K; Chinratanapisit S; Deerojanawong J
    J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S239-45. PubMed ID: 29927174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The association between health costs and physical inactivity; analysis from the Physical Activity at Work study in Thailand.
    Akksilp K; Isaranuwatchai W; Teerawattananon Y; Chen C
    Front Public Health; 2023; 11():1037699. PubMed ID: 36960361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Economic analysis of diabetes care.
    Kapur A
    Indian J Med Res; 2007 Mar; 125(3):473-82. PubMed ID: 17496369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact and disease burden of thalassemia in Thailand: a population-based study in 2010.
    Teawtrakul N; Chansung K; Sirijerachai C; Wanitpongpun C; Thepsuthammarat K
    J Med Assoc Thai; 2012 Jul; 95 Suppl 7():S211-6. PubMed ID: 23130457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study.
    Afroz A; Alam K; Ali L; Karim A; Alramadan MJ; Habib SH; Magliano DJ; Billah B
    BMC Health Serv Res; 2019 Aug; 19(1):601. PubMed ID: 31455307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes in Thailand: Status and Policy.
    Reutrakul S; Deerochanawong C
    Curr Diab Rep; 2016 Mar; 16(3):28. PubMed ID: 26894266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The state of diabetes in North Carolina.
    Konen J; Page J
    N C Med J; 2011; 72(5):373-8. PubMed ID: 22416514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.